Medicinal cannabis company, Organic Genetics, is seeking NZ$4m via equity crowdfunding investment platform, PledgeMe, to accelerate its growth plans including fast-tracking an indoor production facility in Auckland, designed to cultivate premium medicinal craft cannabis and manufacture an extensive product suite.
Founded in 2019 by husband-and-wife duo Paul Lee and Holly Wright, the biotechnology company started with a vision to provide Kiwis with a life-changing and natural alternative to opioids, after seeing their own family members suffer adverse side-effects.
Led in partnership with global cannabis experts, Kind Future, Organic Genetics have assembled a team of industry veterans to share their knowledge and expertise in cannabis cultivation. The company founders believe this will provide Organic Genetics with the insight to avoid the setbacks and challenges that other NZ-based medicinal cannabis companies face, setting themselves apart from other key players in the market.
One of these veterans is Kind Future’s Founder, Jonathan “JJ” Jones, the Vice Executive President at leading cannabis technology and software company, Weedmaps, which is listed on the NASDAQ with a current market capitalisation of US$3.7bn. Jones has a notable track record of success supporting companies to create paths to revenue through product development, marketing, branding and sales.
Read more at scoop.co.nz